Want to see TRS full AI Analyst Report?
Top Page
Trimas
(NASDAQ:TRS)
Select Model
Select Model
Rating:69Neutral
Price Target:
$42.00
▲(4.92% Upside)
Action:Downgraded
Date:07/31/26
The score is driven primarily by improving financial performance (better margins, leverage, and cash flow) and constructive earnings-call guidance with raised EPS expectations. Valuation is a strong positive due to the very low P/E, while the technical setup is a modest drag with the stock trading below key short/intermediate-term moving averages. Corporate events add limited incremental impact.
Positive Factors
Strong balance sheet and net cash
A large cash balance and net cash position give TriMas durable financial flexibility: it can fund operations, taxes, buybacks or targeted M&A without tapping markets. This reduces refinancing risk, supports capital allocation and cushions cyclical demand for multiple quarters.
Negative Factors
Revenue contraction and mixed top-line
A material TTM revenue decline reduces scale and weakens fixed-cost absorption, leaving margins vulnerable to volatility. Mixed demand in key end markets limits sustainable growth, constrains pricing power and makes achieving consistent top-line recovery a medium-term challenge.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong balance sheet and net cash
A large cash balance and net cash position give TriMas durable financial flexibility: it can fund operations, taxes, buybacks or targeted M&A without tapping markets. This reduces refinancing risk, supports capital allocation and cushions cyclical demand for multiple quarters.
Read all positive factors
Trimas (TRS) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.43B
Dividend Yield0.4%
Average Volume (3M)452.29K
Price to Earnings (P/E)1.6
Beta (1Y)0.89
Revenue Growth-21.18%
EPS Growth2519.53%
CountryUS
Employees3,700
SectorConsumer Cyclical
Sector Strength84
IndustryPackaging & Containers
Share Statistics
EPS (TTM)25.56
Shares Outstanding35,827,686
10 Day Avg. Volume334,067
30 Day Avg. Volume452,294
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)2.03
Price to Sales (P/S)2.22
P/FCF Ratio20.72
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$45.00Price Target Upside12.42% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)1.67
Revenue Forecast (FY)$679.48M
Trimas Business Overview & Revenue Model
Company Description
TriMas Corporation (TRS) is a global industrial company focused on the engineering, manufacturing, and distribution of a diverse range of products spanning consumer, aerospace, and industrial markets. Its operations are structured into three prima...
How the Company Makes Money
TriMas makes money primarily by manufacturing and selling engineered components and assemblies through its operating segments. Revenue is generated from (1) Packaging-related products: sales of dispensing pumps, sprayers, closures, and other packa...
Trimas Earnings Call Summary
Earnings Call Date:Jul 30, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Oct 22, 2026
Earnings Call Sentiment Positive
The call conveyed clear operational and financial momentum: significant improvements in profitability, margin expansion, stronger EPS, a very strong balance sheet, disciplined capital allocation including meaningful share repurchases, and raised EPS guidance. However, there are several near-term challenges and transitory headwinds—negative free cash flow in the quarter, temporary resin-cost under-recovery, operational inefficiencies at Norris, and revenue impacts from facility consolidation—that management characterized as addressable and expected to normalize over the balance of the year. The positives around margin expansion, leadership hires, cost-reduction progress, and robust liquidity were emphasized as durable drivers for continued improvement.Positive Updates
Improved Profitability and Earnings
Adjusted operating profit increased 29% year over year to $14.9 million in Q2; adjusted operating margin expanded 180 basis points to 8.5%. Adjusted EPS rose to $0.52 in Q2 from $0.20 a year ago.
Negative Updates
Negative Free Cash Flow in Q2
Second-quarter free cash flow was a use of approximately $12.9 million versus a source of $7.7 million in the prior-year period, driven primarily by timing of sales and collections.
Read all updates
Q2-2026 Updates
Positive
Negative
Improved Profitability and Earnings
Adjusted operating profit increased 29% year over year to $14.9 million in Q2; adjusted operating margin expanded 180 basis points to 8.5%. Adjusted EPS rose to $0.52 in Q2 from $0.20 a year ago.
Read all positive updates
Company Guidance
TriMas reiterated full‑year guidance for total company sales growth of 3%–6% and greater than 300 basis‑points of operating margin improvement versus 2025, raised the lower end of adjusted EPS to $1.60–$1.70 (from $1.50–$1.70), and expects sales, earnings and adjusted EPS to improve in each 2026 quarter versus 2025. By segment, Packaging is guided to +3%–6% sales with 14%–15% operating margins (Q2: ~$143M sales, $21.2M adjusted operating profit, 14.8% margin, +50 bps; Q2 resin cost pressure ~100 bps expected to be recovered cumulatively in Q3–Q4), and Specialty Products’ full‑year sales guidance was raised to +6%–9% with 6%–8% margins (Q2: ~ $32M sales, +10.2% YoY; Q2 operating profit $0.7M, 2.2% margin). Management also reiterated execution of $10.5M of 2026 cost reductions toward a $16M annual run rate, expects sequential margin expansion in Q3, and is assuming no significant redeployment of Aerospace proceeds while maintaining a strong balance sheet (cash >$1.2B, net cash $846M, $175M repurchased YTD, ~35.9M shares outstanding, $76M repurchase authorization remaining, average cash yield 3.7%, $400M of 4.25% notes due 2029).Trimas Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
70
Positive
Cash Flow
67
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 767.61M | 645.72M | 630.80M | 893.55M | 883.83M | 857.11M |
| Gross Profit | 167.20M | 131.24M | 123.20M | 194.86M | 194.31M | 202.43M |
| EBITDA | 121.71M | 99.32M | 80.30M | 124.10M | 155.00M | 137.07M |
| Net Income | 891.03M | 120.14M | 24.25M | 40.36M | 66.17M | 57.31M |
Balance Sheet | ||||||
| Total Assets | 2.25B | 1.49B | 1.32B | 1.34B | 1.30B | 1.30B |
| Cash, Cash Equivalents and Short-Term Investments | 1.24B | 30.02M | 23.07M | 34.89M | 112.09M | 140.74M |
| Total Debt | 40.88M | 505.08M | 442.84M | 443.25M | 444.02M | 445.72M |
| Total Liabilities | 803.04M | 779.49M | 656.88M | 658.71M | 653.17M | 672.79M |
| Stockholders Equity | 1.44B | 705.59M | 667.30M | 682.95M | 651.83M | 630.85M |
Cash Flow | ||||||
| Free Cash Flow | 164.23M | 69.10M | 12.82M | 33.97M | 26.61M | 89.16M |
| Operating Cash Flow | 195.73M | 117.45M | 63.78M | 88.16M | 72.57M | 134.22M |
| Investing Cash Flow | 1.41B | -64.05M | -46.96M | -134.42M | -55.04M | -79.18M |
| Financing Cash Flow | -229.09M | -46.45M | -28.64M | -30.94M | -46.18M | 11.75M |
Trimas Technical Analysis
Positive
40.03
Price Trends
41.13
Negative
39.30
Positive
37.21
Positive
Market Momentum
-0.43
Positive
42.25
Neutral
33.63
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TRS, the sentiment is Positive. The current price of 40.03 is below the 20-day moving average (MA) of 40.39, below the 50-day MA of 41.13, and above the 200-day MA of 37.21, indicating a neutral trend. The MACD of -0.43 indicates Positive momentum. The RSI at 42.25 is Neutral, neither overbought nor oversold. The STOCH value of 33.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TRS.
Trimas Risk Analysis
Trimas disclosed 29 risk factors in its most recent earnings report. Trimas reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Trimas Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $5.57B | 8.70 | 18.34% | 3.66% | 12.01% | ― | |
69 Neutral | $1.43B | 1.56 | 82.44% | 0.40% | -21.18% | 2519.53% | |
69 Neutral | $1.29B | 34.86 | 17.33% | 1.72% | -8.73% | 268.62% | |
62 Neutral | $2.83B | 91.31 | -6.61% | 8.37% | 14.53% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
44 Neutral | $1.10B | -0.95 | -87.88% | ― | -1.85% | -352.80% |
* Consumer Cyclical Sector Average
TRS
Trimas
39.93
5.04
14.46%
MYE
Myers Industries
34.16
18.81
122.60%
OI
O-I Glass
7.15
-5.79
-44.74%
SON
Sonoco Products
56.36
13.54
31.62%
AMBP
Ardagh Metal Packaging
4.73
1.20
34.11%
Trimas Corporate Events
Executive/Board ChangesShareholder Meetings
TriMas Shareholders Approve Directors, Auditor and Executive Pay
Positive
May 21, 2026
TriMas Corporation held its 2026 Annual Meeting of Shareholders on May 20, 2026, with 30,071,708 of 36,685,359 eligible shares represented, constituting a quorum for conducting business. At the meeting, shareholders elected Holly M. Boehne and Her...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.